5

OWNERSHIP DOCUMENT

Company: IOVANCE BIOTHERAPEUTICS, INC.
Filed: January 9, 2013
Period of Report: December 31, 2012
Accession Number: 0001019687-13-000100

View Document ↗ View on SEC.gov ↗